Trials / Unknown
UnknownNCT06212882
Optimization of DE-CTPA Images and Diagnostic Pathway: Using Low Concentration Iodine Contrast Material
Dual-Energy CT Angiography in Suspected Pulmonary Embolism: Influence of Concentration of Contrast Materials on Image Quality and Diagnostic Performance
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,100 (estimated)
- Sponsor
- Wuxi People's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The investigators aimed to compare the image quality and diagnostic performance of DECTPA using lower concentration iodine contrast materials and using normal concentration iodine contrast materials in the evaluation of suspected pulmonary embolism.
Detailed description
All patients met the inclusion and exclusion criteria will be given written informed consensus. The enrolled patients will randomly receive one of the three injection protocols: A: 30mL Iomeprol (Iomeron 300, Bracco Imaging, Milano, Italia) injected at a flow rate of 4mL/s; B: 50mL Iomeprol (Iomeron 300, Bracco Imaging, Milano, Italia) injected at a flow rate of 4mL/s; C: 50mL Ioversol (Ioversol 350, Hengrui, Jiansun, China) injected at a flow rate of 4mL/s. A and B groups are both lower concentration iodine contrast material groups, with different total iodine loads.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Lower concentration and lower volume contrast agent group | CT images using lower concentration and lower volume contrast material |
Timeline
- Start date
- 2023-09-01
- Primary completion
- 2024-11-01
- Completion
- 2025-06-01
- First posted
- 2024-01-19
- Last updated
- 2024-01-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06212882. Inclusion in this directory is not an endorsement.